Learning Objectives:
- Define the diversity of Human Milk Oligosaccharides (HMO) and their potential clinical benefits for the extremely preterm newborns
- Recognize the diverse spectrum and significant concentration of oligosaccharides in human milk as compared to cow milk-based artificial infant formulas
- Explain that industrial processing of donor human milk does not alter the composition, concentration or function of HMO in human milk-derived nutritional products
- Appreciate that an exclusive human milk diet provides not only optimal nutrition for extremely preterm newborns but ensures a full spectrum of HMO responsible for multiple health benefits
Speaker:
Chloe Autran, PhD
HMO Business Development Manager
Prolacta Bioscience
